Several previous publications reported the the higher platelet count and lower leukocyte and hemoglobin values in CALR mutant ET patients compared with those with JAK2 V617F or MPL mutations [[38]–[40]]. The gene discussed is JAK2; the disease is essential thrombocythemia.